You are here

PrEP Acceptability and Access in the U.S. and South Africa

Despite the U.S. FDA's approval of antiretroviral pre-exposure prophylaxis (PrEP) in 2012, uptake of this new HIV prevention strategy has remained comparatively low. This talk will present preliminary results from two NIH-funded studies of challenges and opportunities for the use of PrEP. The first study investigated PrEP acceptability and access among U.S. male sex workers and men who have sex with men. The second study, in South Africa, explored unique challenges facing PrEP implementation in a resource-limited setting.About the Speaker: Dr. Underhill holds a DPhil in Evidence-Based Social Intervention from the University of Oxford, and a JD from Yale Law School. She completed her postdoctoral training in public health at Brown University, and she is currently an Associate Research Scholar and Fellow in Law and Health at Yale. Her research on pre-exposure prophylaxis (PrEP) is funded by a K01 grant from the National Institute of Mental Health, with a focus on PrEP acceptability, access, and user perspectives among male sex workers and men who have sex with men.

Start Date
Tuesday, February 2, 2016
Start Time
12:00 pm
Trent 040